Home APPROVALS Page 2

APPROVALS

Sanofi secures US approval for Nexviazym for late-onset Pompe disease
APPROVALS

Sanofi secures US approval for Nexviazym for late-onset Pompe disease

Dominic Cuthbert -
0
In brief: Roche gains Priority Review for Tecentriq
APPROVALS

In brief: Roche gains Priority Review for Tecentriq

Dominic Cuthbert -
0
FDA expands authorised use of REGEN-COV
APPROVALS

FDA expands authorised use of REGEN-COV

Dominic Cuthbert -
0
Skysona becomes first and only gene therapy approved in EU for CALD
APPROVALS

Skysona becomes first and only gene therapy approved in EU for CALD

Dominic Cuthbert -
0
Roche’s Actemra/RoActemra receives FDA Emergency Use Authorisation
APPROVALS

Roche’s Actemra/RoActemra receives FDA Emergency Use Authorisation

Dominic Cuthbert -
0
Europe approves Aubagio as the first oral MS therapy for paediatric patients
APPROVALS

Europe approves Aubagio as the first oral MS therapy for paediatric patients

Dominic Cuthbert -
0
Accelerated approval for Aduhelm for Alzheimer’s treatment
APPROVALS

Accelerated approval for Aduhelm for Alzheimer’s treatment

Dominic Cuthbert -
0
Comirnaty receives first authorisation in EU for COVID vaccine in adolescents
APPROVALS

Comirnaty receives first authorisation in EU for COVID vaccine in adolescents

Dominic Cuthbert -
0
Alkermes secures FDA approval of Lybalvi for schizophrenia and bipolar I disorder
APPROVALS

Alkermes secures FDA approval of Lybalvi for schizophrenia and bipolar I disorder

Dominic Cuthbert -
0
FDA grant sotrovimab Emergency Use Authorisation
APPROVALS

FDA grant sotrovimab Emergency Use Authorisation

Dominic Cuthbert -
0
123...77Page 2 of 77

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks